Bloomberg Markets & Finance via Youtube

Aug.18 — Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg Markets: China Open.”

READ ALSO  SE: Keiser Report | A New Bretton Woods with China as #1 Power | E1609